---
title: "Prevalence of Osteoporosis and Low Bone Mass in Men with Prostate Cancer: Systematic Review and Me"
id: "pubmed-42828578"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42828578"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42828578/"
doi: "10.1007/s00520-026-11289-3"
published_at: "2026-10-03T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Prevalence of Osteoporosis and Low Bone Mass in Men with Prostate Cancer: Systematic Review and Me
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42828578
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42828578/)
- **DOI:** [10.1007/s00520-026-11289-3](https://doi.org/10.1007%2Fs00520-026-11289-3)
- **Published At:** 2026-10-03T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Prostate cancer (PCa) and its treatments, particularly **androgen-deprivation therapy (ADT)**, are associated with accelerated bone loss and higher risk of osteoporosis and fractures. - This systematic review and meta-analysis pooled data from 52 studies including 91,913 men with PCa to estimate prevalence of **osteoporosis** and **low bone mass**. - Osteoporosis was defined primarily by BMD T-score ≤ -2.5; low bone mass (osteopenia) by T-score > -2.5 to 92%. - Sensitivity analyses produced results consistent with primary analyses. - The review highlights the frequent documentation of **osteoporosis** and **low bone mass** among men with PCa but emphasizes substantial limitations due to heterogeneity, variable densitometric methods, and diagnostic definitions. - The study assessed prevalence only and did not evaluate fracture incidence, screening effectiveness, or treatment efficacy; it cannot support conclusions about interventions reducing fracture risk. - The authors call for standardized longitudinal studies with harmonized **bone mineral density (BMD)** assessment to better inform bone-health management in PCa populations.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42828578/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42828578%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42828578/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42828578/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42828578/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42828578/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42828578/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42828578/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42828578%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42828578%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42828578/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42828578/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42828578/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42828578/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42828578/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42828578/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42828578/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42828578/#conflict-of-interest) * [ References ](https://pubmed.ncbi.nlm.nih.gov/42828578/#references) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/42828578/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42828578/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42828578/#substances) Title & authors Abstract Conflict of interest statement References Publication types MeSH terms Substances Review Support Care Cancer Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Support+Care+Cancer%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Support+Care+Cancer%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42828578/) . 2026 Oct 3;34(10):1053. doi: 10.1007/s00520-026-11289-3. # Prevalence of osteoporosis and low bone mass in men with prostate cancer: a systematic review and meta-analysis [Mehdi Ebrahimi](https://pubmed.ncbi.nlm.nih.gov/?term=Ebrahimi+M&cauthor_id=42828578)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#full-view-affiliation-1 "Department of Internal Medicine, Faculty of Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran."), [Abdolreza Mohammadi](https://pubmed.ncbi.nlm.nih.gov/?term=Mohammadi+A&cauthor_id=42828578)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#full-view-affiliation-2 "Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran."), [Sogand Sarmadi](https://pubmed.ncbi.nlm.nih.gov/?term=Sarmadi+S&cauthor_id=42828578)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#full-view-affiliation-3 "Department of Medical‑Surgical Nursing, Shahid Beheshti University of Medical Sciences, Tehran, Iran."), [Ramin Rahimnia](https://pubmed.ncbi.nlm.nih.gov/?term=Rahimnia+R&cauthor_id=42828578)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#full-view-affiliation-4 "Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran."), [Akbar Zare-Kaseb](https://pubmed.ncbi.nlm.nih.gov/?term=Zare-Kaseb+A&cauthor_id=42828578)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#full-view-affiliation-3 "Department of Medical‑Surgical Nursing, Shahid Beheshti University of Medical Sciences, Tehran, Iran."), [Leonardo Olivia Reis](https://pubmed.ncbi.nlm.nih.gov/?term=Reis+LO&cauthor_id=42828578)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#full-view-affiliation-5 "UroScience and Department of Surgery \(Urology\), School of Medical Sciences, University of Campinas, Unicamp, and Pontifical Catholic University of Campinas, PUC-Campinas, São Paulo, Campinas, Brazil."), [Alireza Namazi Shabestari](https://pubmed.ncbi.nlm.nih.gov/?term=Shabestari+AN&cauthor_id=42828578)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#full-view-affiliation-6 "Department of Geriatric Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran."), [Neda Sanaie](https://pubmed.ncbi.nlm.nih.gov/?term=Sanaie+N&cauthor_id=42828578)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#full-view-affiliation-3 "Department of Medical‑Surgical Nursing, Shahid Beheshti University of Medical Sciences, Tehran, Iran."), [Abbasali Keshtkar](https://pubmed.ncbi.nlm.nih.gov/?term=Keshtkar+A&cauthor_id=42828578)[ 7 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#full-view-affiliation-7 "Department of Disaster and Emergency Health, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran."), [Seyed Mohammad Kazem Aghamir](https://pubmed.ncbi.nlm.nih.gov/?term=Aghamir+SMK&cauthor_id=42828578)[ 8 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#full-view-affiliation-8 "Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran. mkaghamir@tums.ac.ir.") Affiliations Expand ### Affiliations * 1 Department of Internal Medicine, Faculty of Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran. * 2 Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran. * 3 Department of Medical‑Surgical Nursing, Shahid Beheshti University of Medical Sciences, Tehran, Iran. * 4 Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. * 5 UroScience and Department of Surgery (Urology), School of Medical Sciences, University of Campinas, Unicamp, and Pontifical Catholic University of Campinas, PUC-Campinas, São Paulo, Campinas, Brazil. * 6 Department of Geriatric Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. * 7 Department of Disaster and Emergency Health, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. * 8 Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran. mkaghamir@tums.ac.ir. * PMID: **42828578** * DOI: [ 10.1007/s00520-026-11289-3 ](https://doi.org/10.1007/s00520-026-11289-3) Item in Clipboard Review # Prevalence of osteoporosis and low bone mass in men with prostate cancer: a systematic review and meta-analysis Mehdi Ebrahimi et al. Support Care Cancer. 2026. Show details Display options Display options Format Abstract PubMed PMID Support Care Cancer Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Support+Care+Cancer%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Support+Care+Cancer%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42828578/) . 2026 Oct 3;34(10):1053. doi: 10.1007/s00520-026-11289-3. ### Authors [Mehdi Ebrahimi](https://pubmed.ncbi.nlm.nih.gov/?term=Ebrahimi+M&cauthor_id=42828578)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#short-view-affiliation-1 "Department of Internal Medicine, Faculty of Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran."), [Abdolreza Mohammadi](https://pubmed.ncbi.nlm.nih.gov/?term=Mohammadi+A&cauthor_id=42828578)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#short-view-affiliation-2 "Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran."), [Sogand Sarmadi](https://pubmed.ncbi.nlm.nih.gov/?term=Sarmadi+S&cauthor_id=42828578)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#short-view-affiliation-3 "Department of Medical‑Surgical Nursing, Shahid Beheshti University of Medical Sciences, Tehran, Iran."), [Ramin Rahimnia](https://pubmed.ncbi.nlm.nih.gov/?term=Rahimnia+R&cauthor_id=42828578)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#short-view-affiliation-4 "Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran."), [Akbar Zare-Kaseb](https://pubmed.ncbi.nlm.nih.gov/?term=Zare-Kaseb+A&cauthor_id=42828578)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#short-view-affiliation-3 "Department of Medical‑Surgical Nursing, Shahid Beheshti University of Medical Sciences, Tehran, Iran."), [Leonardo Olivia Reis](https://pubmed.ncbi.nlm.nih.gov/?term=Reis+LO&cauthor_id=42828578)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#short-view-affiliation-5 "UroScience and Department of Surgery \(Urology\), School of Medical Sciences, University of Campinas, Unicamp, and Pontifical Catholic University of Campinas, PUC-Campinas, São Paulo, Campinas, Brazil."), [Alireza Namazi Shabestari](https://pubmed.ncbi.nlm.nih.gov/?term=Shabestari+AN&cauthor_id=42828578)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#short-view-affiliation-6 "Department of Geriatric Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran."), [Neda Sanaie](https://pubmed.ncbi.nlm.nih.gov/?term=Sanaie+N&cauthor_id=42828578)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#short-view-affiliation-3 "Department of Medical‑Surgical Nursing, Shahid Beheshti University of Medical Sciences, Tehran, Iran."), [Abbasali Keshtkar](https://pubmed.ncbi.nlm.nih.gov/?term=Keshtkar+A&cauthor_id=42828578)[ 7 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#short-view-affiliation-7 "Department of Disaster and Emergency Health, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran."), [Seyed Mohammad Kazem Aghamir](https://pubmed.ncbi.nlm.nih.gov/?term=Aghamir+SMK&cauthor_id=42828578)[ 8 ](https://pubmed.ncbi.nlm.nih.gov/42828578/#short-view-affiliation-8 "Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran. mkaghamir@tums.ac.ir.") ### Affiliations * 1 Department of Internal Medicine, Faculty of Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran. * 2 Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran. * 3 Department of Medical‑Surgical Nursing, Shahid Beheshti University of Medical Sciences, Tehran, Iran. * 4 Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. * 5 UroScience and Department of Surgery (Urology), School of Medical Sciences, University of Campinas, Unicamp, and Pontifical Catholic University of Campinas, PUC-Campinas, São Paulo, Campinas, Brazil. * 6 Department of Geriatric Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. * 7 Department of Disaster and Emergency Health, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. * 8 Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran. mkaghamir@tums.ac.ir. * PMID: **42828578** * DOI: [ 10.1007/s00520-026-11289-3 ](https://doi.org/10.1007/s00520-026-11289-3) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract **Background:** Prostate cancer (PCa) and its treatments, notably androgen-deprivation therapy (ADT), are linked to accelerated bone loss, thereby elevating the risk of osteoporosis and fractures. Nevertheless, comprehensive data on the prevalence of osteoporosis and low bone mass (osteopenia) in men with PCa are still limited. **Objective:** To systematically review and meta-analyze the prevalence of osteoporosis and low bone mass in adult men with PCa at all disease stages, and to investigate study-level factors such as ADT category and duration that might influence these estimates. **Methods:** We conducted a systematic search of PubMed, Scopus, Web of Science, Embase, CINAHL, and ProQuest for studies published between January 1994 and October 2025. Population- or institution-based cross-sectional and cohort studies reporting the prevalence of osteoporosis or low bone mass among adult PCa patients were included. Osteoporosis and low bone mass were classified primarily according to BMD T-score thresholds of ≤ - 2.5 and > - 2.5 to < - 1.0, respectively, while study-specific definitions and ascertainment methods were recorded and considered in subgroup analyses. Risk-of-bias assessment was independently performed using the Joanna Briggs Institute checklist. Pooled prevalence estimates were calculated using random-effects meta-analysis, and heterogeneity was assessed using the I2 statistic. Subgroup, meta-regression, and sensitivity analyses were conducted to explore potential sources of heterogeneity. **Results:** Fifty-two studies comprising 91,913 men with PCa were included. All 52 studies contributed to the osteoporosis analysis (7,042 reported cases), and 42 studies contributed to the low bone mass analysis. The pooled prevalence of osteoporosis was 22.0% (95% CI: 19.9-24.1; I2 = 99.49%), and that of low bone mass was 41.7% (95% CI: 36.6-46.9; I2 = 95.85%). Pooled estimates varied across BMD ascertainment methods, outcome definitions, ADT categories, geographic regions, and study designs; the largest differences were methodological rather than clinical, and many subgroups contained only one or two studies, so these comparisons are exploratory. Meta-regression found no statistically significant links between publication year or ADT duration and overall prevalence. However, since ADT duration data were available for only 24 studies on osteoporosis and 20 on low bone mass, and residual heterogeneity remained above 92%, the lack of a detected association does not rule out a real connection. Sensitivity analyses yielded results similar to the main findings. **Conclusions:** Osteoporosis and low bone mass are frequently documented among men with PCa, although pooled estimates are limited by substantial heterogeneity across populations, densitometric methods, and diagnostic definitions. These data underscore the importance of considering bone health in PCa management protocols; however, this review assessed only prevalence and did not evaluate fracture incidence, screening effectiveness, or treatment efficacy. Consequently, it cannot confirm that any particular intervention diminishes fracture risk. There is a need for standardized longitudinal studies with harmonized BMD assessment. **Keywords:** Androgen-deprivation therapy; Bone mineral density; Low bone mass; Meta-analysis; Osteopenia; Osteoporosis; Prostate cancer. © 2026. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declarations. Ethics approval and consent to participate: Not applicable. Permission to reproduce material from other sources: There are no materials from other sources. Clinical trial number: Not applicable. Consent for publication: Not applicable. Declaration of generative AI and AI-assisted technologies in the writing process: During the revision of this manuscript, the authors used Claude (Anthropic) solely to improve its language, grammar, clarity, and readability. The AI-assisted suggestions were critically reviewed and edited by the authors, who retained full responsibility for the accuracy, integrity, interpretation, and final content of the manuscript. Competing interests: The authors declare no competing interests. ## References 1. 1. Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O et al (2022) 2022 update on prostate cancer epidemiology and risk factors—a systematic review. Eur Urol 84(2):191–206 - [DOI](https://doi.org/10.1016/j.eururo.2023.04.021) 2. 1. Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10(2):63 - [PubMed](https://pubmed.ncbi.nlm.nih.gov/31068988/) - [PMC](https://pmc.ncbi.nlm.nih.gov/articles/6497009/) - [DOI](https://doi.org/10.14740/wjon1191) 3. 1. Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A (2020) R
## Related Clinical Research

- [Reassessing Breast Cancer Treatment: The Benefits of De-Escalation](https://medichelpline.com/clinical-feed/plos-medicine-0-breast-cancer-treatment-when-less-is-more.md)
- [Lifestyle strategies for ADT-induced osteosarcopenia and metabolic dysfunction in prostate cancer](https://medichelpline.com/clinical-feed/pubmed-43064850.md) (DOI: 10.1007/s00520-026-11504-1)
- [COMMD1 in Cancer: Dual Roles, Mechanisms, and Translational Targets](https://medichelpline.com/clinical-feed/pubmed-43059391.md) (DOI: 10.3892/or.2026.9224)
- [Gland MRI Radiomics Predicts Time to Pathologic Progression on Prostate Cancer Active Surveillance](https://medichelpline.com/clinical-feed/medrxiv-6-automated-gland-mri-radiomics-for-predicting-time-to-pathologic-progression.md)
- [Germline genomic score P-CARE adds risk information beyond PSA for short- and long-term prostate c](https://medichelpline.com/clinical-feed/medrxiv-22-additional-value-of-germline-genomic-scores-beyond-prostate-specific-antigen.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.